Ashley J. Dittmar, Ph.D.
Affiliations: | 2013 | Roswell Park . Cellular and Molecular Biology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Genetics, OncologyGoogle:
"Ashley Dittmar"Parents
Sign in to add mentorPeter Demant | grad student | 2013 | SUNY Buffalo | |
(A novel type of non-PK related genes controls susceptibility to the toxic effects of irinotecan.) | ||||
Ira Blader | post-doc | 2013- | SUNY Buffalo (Microtree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Baptista CG, Lis A, Deng B, et al. (2019) Toxoplasma F-box protein 1 is required for daughter cell scaffold function during parasite replication. Plos Pathogens. 15: e1007946 |
Dittmar AJ, Drozda AA, Blader IJ. (2016) Drug Repurposing Screening Identifies Novel Compounds That Effectively Inhibit Toxoplasma gondii Growth. Msphere. 1 |
Demant P, Thudium KE, Sepporta MV, et al. (2015) Comprehensive genetic definition of susceptibility to toxic side effects of irinotecan in mice. Journal of Clinical Oncology. 33: e13566-e13566 |
Brown KM, Suvorova E, Farrell A, et al. (2014) Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases. Plos Pathogens. 10: e1004180 |
Brown KM, Suvorova E, Farrell A, et al. (2014) Forward Genetic Screening Identifies a Small Molecule That Blocks Toxoplasma gondii Growth by Inhibiting Both Host- and Parasite-Encoded Kinases Plos Pathogens. 10 |
Dittmar AJ, Affronti H, Sepporta MV, et al. (2013) Genetic susceptibility to toxicity of chemotherapy in mice as pharmacokinetics-independent and drug-specific. Journal of Clinical Oncology. 31 |
Quan L, Dittmar A, Zhou Y, et al. (2012) Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice. Genes, Chromosomes & Cancer. 51: 631-43 |